title: Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use.
authors.affiliation: Yale University, School of Medicine, Department of Psychiatry, West Haven, CT 06516, USA. mehmet.sofuoglu@yale.edu
authors.forename: Mehmet
authors.initials: M
authors.lastname: Sofuoglu
mesh_terms: D019969:Amphetamine-Related Disorders / Q000534:rehabilitation*; D005260:Female; D018757:GABA Modulators / Q000008:administration & dosage*; D017442:Histamine Agonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008694:Methamphetamine
chemical_list: D018757:GABA Modulators; D017442:Histamine Agonists; D008694:Methamphetamine